Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

about

Network analysis of membranous glomerulonephritis based on metabolomics data

P2860

Q57158102-56E77788-1A78-4B94-9AC5-96ECB31193F9

P2860

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

Item

http://www.wikidata.org/entity/Q55251661

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

@en

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

@nl

type

Item

label

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

@en

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

@nl

altLabel

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease

@en

prefLabel

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

@en

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

@nl

P1476

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

@en

P2093

Alberto Canepa

http://www.w3.org/2001/XMLSchema#string

Alice Bonanni

http://www.w3.org/2001/XMLSchema#string

G. M. Ghiggeri

http://www.w3.org/2001/XMLSchema#string

Roberta Bertelli

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in EMP2 cause childhood-onset nephrotic syndrome

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible

Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

The Efficacy and Safety of Antiinterleukin 13, a Monoclonal Antibody, in Adult Patients With Asthma: A Systematic Review and Meta-Analysis

New insights into human minimal change disease: lessons from animal models

Basic and translational concepts of immune-mediated glomerular diseases

Association of DQB1*0302 alloantigens in Japanese pediatric patients with steroid-sensitive nephrotic syndrome

Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis

LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity

P304

170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMED.2018.00170

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gianluca Caridi

P577

2018-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29942802

http://www.w3.org/2001/XMLSchema#string

P932

6004767

http://www.w3.org/2001/XMLSchema#string

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

about

P2860

P2860

Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932